N-terminal pro-brain natriuretic peptide test (NT-proBNP), the gold standard biomarker1 in heart failure, can now be used to assess the risk of heart failure in patients with Type 2 Diabetes2 and to help in stroke prevention in elderly individuals at risk for Atrial Fibrillation.3
Following both cardiac and non-cardiac procedures, recent data confirmed the value of high sensitivity cardiac troponin(hs-cTnT), where in perioperative use it can be used to predict major adverse cardiac events (MACE).4-6
Both Elecsys® NT-proBNP and Elecsys® cTnT-hs can be run on all cobas e analysers. They are among the first products certified under the new European In Vitro Diagnostics Regulation (IVDR) and available as of today in countries accepting CE mark. Availability in other countries is subject to local registration processes and timelines.